<DOC>
	<DOCNO>NCT01067742</DOCNO>
	<brief_summary>The purpose study define natural history Mucolipidosis Type IV identify potential clinical outcome measure .</brief_summary>
	<brief_title>The Natural History Mucolipidosis Type IV</brief_title>
	<detailed_description>Mucolipidosis type IV ( MLIV ) autosomal recessive disorder typically characterize severe psychomotor delay evident end first year life slowly progressive visual impairment first decade result combination corneal cloud retinal degeneration . By end first decade life , always early teen , individual typical MLIV develop severe visual impairment result retinal degeneration . MLIV under-diagnosed unique lysosomal disorder often mistake either cerebral palsy retinal dystrophy unknown cause . In addition , cause defect cation channel rather lysosomal hydrolase . This study represent prospective clinical study patient population . Now animal model create novel therapy likely test , particularly important define natural history disorder identify potential clinical outcome measure .</detailed_description>
	<mesh_term>Mucolipidoses</mesh_term>
	<criteria>Subjects must : Have definitive diagnosis MLIV base least compatible history significantly elevate blood gastrin level Be able travel Baylor Institute Metabolic Disease Dallas spend 23 work day site Be able tolerate general exam neurological exam Be able tolerate modest amount blood drawing , provide urine specimen , skin biopsy ( previously do ) Be able tolerate performance necessary neuroimaging study include EEG Head MRI Be able tolerate neuropsychological test rehabilitation evaluation</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Mucolipidosis , retinal dystrophy , mucolipin-1 ,</keyword>
	<keyword>lysosomal storage disease , gastrin , mental retardation ,</keyword>
	<keyword>dysmyelination , dysplastic corpus callosum , corneal clouding</keyword>
</DOC>